Miramar Capital’s Pfizer PFE Stock Holding History

Miramar Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,354	Closed	-$300K	–	88
2023 Q1	$300K	Sell	7,354 -4,127	-36%	-$178K	0.08%	66
2022 Q4	$588K	Sell	11,481 -5,092	-31%	-$244K	0.15%	52
2022 Q3	$774K	Sell	16,573 -789	-5%	-$38.3K	0.21%	48
2022 Q2	$910K	Buy	17,362 +59	+0.3%	+$3.01K	0.26%	41
2022 Q1	$896K	Buy	17,303 +11,383	+192%	+$591K	0.25%	50
2021 Q4	$350K	Hold	5,920	–	–	0.12%	46
2021 Q3	$255K	Hold	5,920	–	–	0.1%	48
2021 Q2	$267K	Buy	+5,920	New	+$230K	0.11%	47
2021 Q1	–	Sell	-10,306	Closed	-$359K	–	63
2020 Q4	$359K	Buy	10,306 +4,405	+75%	+$162K	0.16%	51
2020 Q3	$206K	Sell	5,901 -1,054	-15%	-$37K	0.12%	49
2020 Q2	$253K	Buy	+6,955	New	+$236K	0.16%	43
2019 Q4	–	Sell	-5,913	Closed	-$205K	–	57
2019 Q3	$205K	Sell	5,913 -38,417	-87%	-$1.4M	0.14%	54
2019 Q2	$1.79M	Buy	44,330 +2,300	+5%	+$91.3K	1.27%	29
2019 Q1	$1.69M	Sell	42,030 -42,213	-50%	-$1.69M	1.3%	28
2018 Q4	$3.35M	Buy	+84,243	New	+$3.5M	2.62%	20

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Miramar Capital's PFE Position: Q2 2023 in Review

Miramar Capital sold out of Pfizer (PFE) in Q2 2023, closing a stake of 7,354 shares — an estimated $300K sold.

Miramar Capital first reported a position in PFE in Q4 2018 and held it in 15 quarters. The position peaked at $3.35M in Q4 2018. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

Miramar Capital reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
Miramar Capital sold 7,354 Pfizer shares in Q2 2023, an estimated $300K.
Miramar Capital first reported a position in Pfizer in Q4 2018 and held it in 15 quarters.
Miramar Capital's Pfizer position peaked at $3.35M in Q4 2018.
3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Miramar Capital's 13F filing for Q2 2023, filed 11 Aug 2023.